Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents

被引：7

作者：

Saul, Dominik ^{[1
,2
,3
]}

Drake, Matthew T. ^{[1
,2
]}

机构：

[1] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN 55905 USA

[2] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA

[3] Univ Gottingen, Dept Trauma Surg Orthopaed & Plast Surg, Robert Koch Str 40, D-37075 Gottingen, Germany

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2021年 / 50卷 / 02期

关键词：

Osteoporosis; Postmenopausal; Bone; Anti-resorptive; Anabolic; Combination; Sequential; BONE-MINERAL DENSITY; FRACTURE RISK REDUCTION; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; ZOLEDRONIC ACID; RANDOMIZED-TRIAL; TERIPARATIDE; DENOSUMAB; ALENDRONATE; RISEDRONATE;

D O I：

10.1016/j.ecl.2021.03.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：179 / 191

页数：13

共 57 条

[11] T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial [J].

Cosman, Felicia ;

Lewiecki, E. Michael ;

Ebeling, Peter R. ;

Hesse, Eric ;

Napoli, Nicola ;

Matsumoto, Toshio ;

Crittenden, Daria B. ;

Rojeski, Maria ;

Yang, Wenjing ;

Libanati, Cesar ;

Ferrari, Serge .

JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (07) :1333-1342

[12] Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis [J].

Cosman, Felicia ;

Nieves, Jeri W. ;

Dempster, David W. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (02) :198-202

[13] Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1-34)] in Postmenopausal Osteoporosis [J].

Cosman, Felicia ;

Eriksen, Erik Fink ;

Recknor, Chris ;

Miller, Paul D. ;

Guanabens, Nuria ;

Kasperk, Christian ;

Papanastasiou, Philemon ;

Readie, Aimee ;

Rao, Hanumantha ;

Gasser, Juerg A. ;

Bucci-Rechtweg, Christina ;

Boonen, Steven .

JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) :503-511

[14] Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension [J].

Cummings, Steven R. ;

Ferrari, Serge ;

Eastell, Richard ;

Gilchrist, Nigel ;

Jensen, Jens-Erik Beck ;

McClung, Michael ;

Roux, Christian ;

Torring, Ove ;

Valter, Ivo ;

Wang, Andrea T. ;

Brown, Jacques P. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (02) :190-198

[15] Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis [J].

Cummings, Steven R. ;

San Martin, Javier ;

McClung, Michael R. ;

Siris, Ethel S. ;

Eastell, Richard ;

Reid, Ian R. ;

Delmas, Pierre ;

Zoog, Holly B. ;

Austin, Matt ;

Wang, Andrea ;

Kutilek, Stepan ;

Adami, Silvano ;

Zanchetta, Jose ;

Libanati, Cesar ;

Siddhanti, Suresh ;

Christiansen, Claus .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08) :756-765

[16] Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis [J].

Dempster, David W. ;

Brown, Jacques P. ;

Fahrleitner-Pammer, Astrid ;

Kendler, David ;

Rizzo, Sebastien ;

Valter, Ivo ;

Wagman, Rachel B. ;

Yin, Xiang ;

Yue, Susan, V ;

Boivin, Georges .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (07) :2498-2509

[17]

Dhaliwal R, 2020, JBMR PLUS, V4, P10346

[18] Bisphosphonates: Mechanism of action and role in clinical practice [J].

Drake, Mathew T. ;

Clarke, Bart L. ;

Khosla, Sundeep .

MAYO CLINIC PROCEEDINGS, 2008, 83 (09) :1032-1045

[19] The Pathophysiology and Treatment of Osteoporosis [J].

Drake, Matthew T. ;

Clarke, Bart L. ;

Lewiecki, E. Michael .

CLINICAL THERAPEUTICS, 2015, 37 (08) :1837-1850

[20]

European Medicines Agency, 2018, ASS REP EL INT NONPR

← 1 2 3 4 5 6 →